Skip to main content
. 2017 Jul 21;313(4):H744–H756. doi: 10.1152/ajpheart.00280.2017

Fig. 2.

Fig. 2.

Tumor necrosis factor-α (TNF-α) receptor 1 (TNFR1) immunoreactivity (red) in the subfornical organ (SFO) and surrounding area (top) and in the hypothalamic paraventricular nucleus (PVN; bottom) 1 wk after SFO microinjection of vehicle (Veh; left) or TNFR1 shRNA (right). SFO microinjection of TNFR1 shRNA reduced TNFR1 immunoreactivity in the SFO but did not affect TNFR1 immunoreactivity in the PVN, which was minimal. Scale bar = 100 µm.